Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Cancer Research UK
ABM Therapeutics Corporation
OHSU Knight Cancer Institute
Hoffmann-La Roche
Peter MacCallum Cancer Centre, Australia
Revolution Medicines, Inc.